Recent News


Telix pharmaceuticals and atlab pharma agreement

Telix pharmaceuticals and atlab pharma conclude therapeutic product development agreement for prostate cancer... Read More →

Linda Evangelista Appointed as New Creative Director for ERASA XEP-30

BioMimetic Laboratories’ revolutionary skincare product adds fashion and beauty icon to product innovation and brand management team. coverage (EN)... Read More →

OGD2 Pharma and Syndivia launch collaboration to develop an Antibody-Drug Conjugate (ADC) targeting the O-acetyl-GD2 cancer antigen

A few months after announcing its collaboration with the Korean pharmaceutical company GreenCross in cell therapy, OGD2 Pharma is getting... Read More →

Why Choose Us?

Team up with us, we hold a successful track record in Health & Beauty, and bring our expertise at every step of your development.

Get in touch

Invest in us, we are bringing a handful of exciting innovations to the market and focus on building long-term, trustworthy relationships.

Get in touch

Co-invest with us, we look for relevant partners to join forces and broaden the scope of our investments to growth capital opportunities.

Get in touch

Some of our holdings:


Back to Top